Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

603 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.
Rauner M, Baschant U, Roetto A, Pellegrino RM, Rother S, Salbach-Hirsch J, Weidner H, Hintze V, Campbell G, Petzold A, Lemaitre R, Henry I, Bellido T, Theurl I, Altamura S, Colucci S, Muckenthaler MU, Schett G, Komla Ebri D, Bassett JHD, Williams GR, Platzbecker U, Hofbauer LC. Rauner M, et al. Among authors: platzbecker u. Nat Metab. 2019 Jan;1(1):111-124. doi: 10.1038/s42255-018-0005-8. Epub 2019 Jan 7. Nat Metab. 2019. PMID: 30886999 Free PMC article.
Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.
Wobus M, Benath G, Ferrer RA, Wehner R, Schmitz M, Hofbauer LC, Rauner M, Ehninger G, Bornhäuser M, Platzbecker U. Wobus M, et al. Among authors: platzbecker u. Exp Hematol. 2012 Oct;40(10):867-76. doi: 10.1016/j.exphem.2012.06.004. Epub 2012 Jun 15. Exp Hematol. 2012. PMID: 22705469 Free article. Clinical Trial.
Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.
Ferrer RA, Wobus M, List C, Wehner R, Schönefeldt C, Brocard B, Mohr B, Rauner M, Schmitz M, Stiehler M, Ehninger G, Hofbauer LC, Bornhäuser M, Platzbecker U. Ferrer RA, et al. Among authors: platzbecker u. Haematologica. 2013 Nov;98(11):1677-85. doi: 10.3324/haematol.2013.083972. Epub 2013 May 28. Haematologica. 2013. PMID: 23716561 Free PMC article.
Macroglossia as the only presenting feature of amyloidosis due to MGUS.
Tsourdi E, Därr R, Wieczorek K, Röcken C, Ehehalt F, Conrad K, Platzbecker U, Hofbauer LC. Tsourdi E, et al. Among authors: platzbecker u. Eur J Haematol. 2014 Jan;92(1):88-9. doi: 10.1111/ejh.12163. Epub 2013 Jul 25. Eur J Haematol. 2014. PMID: 23799910 No abstract available.
Myelodysplasia is in the niche: novel concepts and emerging therapies.
Bulycheva E, Rauner M, Medyouf H, Theurl I, Bornhäuser M, Hofbauer LC, Platzbecker U. Bulycheva E, et al. Among authors: platzbecker u. Leukemia. 2015 Feb;29(2):259-68. doi: 10.1038/leu.2014.325. Epub 2014 Nov 14. Leukemia. 2015. PMID: 25394715 Free PMC article. Review.
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation.
Jaekel N, Lieder K, Albrecht S, Leismann O, Hubert K, Bug G, Kröger N, Platzbecker U, Stadler M, de Haas K, Altamura S, Muckenthaler MU, Niederwieser D, Al-Ali HK. Jaekel N, et al. Among authors: platzbecker u. Bone Marrow Transplant. 2016 Jan;51(1):89-95. doi: 10.1038/bmt.2015.204. Epub 2015 Sep 14. Bone Marrow Transplant. 2016. PMID: 26367238 Clinical Trial.
603 results